Abstract:Background: Lysophosphatidic acid (LPA) is an important extracellular signal transmitter and intracellular second messenger in body fluids. It can be detected in the ascitic fluid of patients with ovarian cancer. Increasing evidence shows that LPA can stimulate cancer cell proliferation and promote tumor invasion and metastasis. Our study aimed to evaluate the diagnostic value of LPA in differentiating between malignant pleural effusions (MPEs) and benign pleural effusions (BPEs) and to evaluate the association between the level of LPA in MPE and the prognosis of lung cancer patients.Patients and methods: The level of LPA in the pleural effusions (PEs) of 123 patients (94 MPE, 29 BPE) with lung cancer was evaluated using an enzyme-linked immunosorbent assay. The performance of LPA was analyzed by standard Receiver operator characteristic curve (ROC) analysis methods, using the area under the curve (AUC) as a measure of accuracy. Overall survival (OS) curves and progression-free survival (PFS) curves were based on the Kaplan-Meier method, and the survival differences between subgroups were analyzed using the log-rank or Breslow test (SPSS software). A multivariate Cox proportional hazards model was used to assess whether LPA independently predicted lung cancer survival.Results: The levels of LPA differed significantly between MPE (22.08 +/- 8.72 mu g/L) and BPE (14.61 +/- 5.12 mu g/L) (P<0.05). Using a cutoff point of 18.93 mu g/L, LPA had a sensitivity of 60% and a specificity of 83% to distinguish MPEs from BPEs with an AUC of 0.769 +/- 0.045 (SE) (P=0.000) (95% CI, 0.68-0.857). In the three pathological types of lung cancer patients with MPE, there were no significant associations between LPA levels and the length of PFS and OS (P=0.58 and 0.186, respectively). Interestingly, in the patients with MPE caused by lung adenocarcinoma there were significant associations between the LPA levels and the PFS and OS (P=0.018 and 0.026, respectively). Multivariate analysis showed that the LPA level was an independent prognostic factor for PFS in lung adenocarcinoma.Conclusions: Our results indicate that LPA can be used as a new biomarker for the diagnosis of MPE caused by lung cancer and that higher levels of LPA are related to shorter PFS in adenocarcinoma of the lung.

The study of pleural lavage cytology for lung cancer

Study of Telomerase Activity in Pleural Lavage Fluid Specimens in Patients with Non-Small-cell Lung Cancer and Its Clinical Significance

The Clinical Value of Pleural Lavage Cytology During Operation for Lung Cancer

Cytology Cell Blocks from Malignant Pleural Effusion Are Good Candidates for PD-L1 Detection in Advanced NSCLC Compared with Matched Histology Samples

Diagnostic Value of Thin-Cytological Test and Routine Cytological Detection for Patients

Pleural fluid analysis of lung cancer vs benign inflammatory disease patients

Correlation Between the Expression of PD-L1 in Pleural Effusion of Lung Adenocarcinoma and the Clinicopathological Features and Molecular Changes

Application of liquid-based cytology test of bronchial lavage fluid in lung cancer diagnosis

Diagnostic Accuracy of Cancer in Pleural Effusion: A Combination Serum Tumor Markers and Cytology

Clinical Analysis of 172 Cases of Malignant Pleural Effusion with Lung Cancer

[Pulmonary Adenocarcinoma in Situ with Positive Findings in Pleural Lavage Cytology]

The detection of PD‐L1 expression on liquid‐based cytology in pleural effusion of lung adenocarcinoma and its prognostic evaluation: Between paired liquid‐based cytology and cell block samples

The expression levels of VEGF and ICAM-1 in pleural effusion

Clinical study on pleural lavage for chest infection after thoracotomy

The investigation of the volatile metabolites of lung cancer from the microenvironment of malignant pleural effusion

DNA content,the expression of VEGF and p53 in pleural effusion can predict the cure and prognosis

Can cell‐free DNA (cfDNA) in pleural lavage serve as a predictive and prognostic biomarker among surgically treated Stage I−III a nonsmall cell lung cancer (NSCLC)? A pilot study

Diagnostic sensitivity of pleural fluid cytology in malignant pleural effusions: systematic review and meta-analysis

Diagnostic and Prognostic Significance of Lysophosphatidic Acid in Malignant Pleural Effusions.

A study of pleural effusion in genomic detection of lung adenocarcinoma